Post by A*STAR Infectious Diseases Labs - A*STAR IDL

✨ 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝘀𝘁𝗿𝗼𝗻𝗴𝗲𝗿 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗳𝘂𝘁𝘂𝗿𝗲 𝗶𝗻𝗳𝗹𝘂𝗲𝗻𝘇𝗮 𝘁𝗵𝗿𝗲𝗮𝘁𝘀 We’re excited to embark on this meaningful collaboration with Apriori Bio to co-develop saRNA vaccine candidates against emerging H5 influenza threats. A great opportunity to combine AI-guided antigen design with our saRNA platform to accelerate next-generation vaccine innovation. Looking forward to advancing solutions that strengthen long-term preparedness and public health resilience. 💉🔬🤝 #InnovatewithASTAR #EnhancingLives #PublicHealth #Vaccine #Innovation #Partnerships